| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.19 | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.19 | experimental | ligand |
| cinolazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.13 | experimental | ligand |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.13 | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.14 | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.14 | experimental | ligand |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
NA | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.14 | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.14 | experimental | ligand |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
NA | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.18 | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.16 | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.18 | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.18 | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.18 | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.18 | experimental | ligand |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.18 | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.11 | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.11 | experimental | ligand |
| cinolazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.15 | experimental | ligand |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.15 | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.18 | experimental | positive allosteric modulator |
| cinolazepam | gaba(a) receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
NA | experimental | positive allosteric modulator |
| cinolazepam | translocator protein | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Anxiety Disorders[MeSHID:D001008] Depressive Symptoms[MeSHID:D003863] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Spasm[MeSHID:D013035] |
0.11 | approved | unknown |
| click here to return to the previous page | ||||||||